• Publications
  • Influence
The Potential for Misuse and Abuse of Medications in ADHD: A Review
Abstract This article reviews the literature concerning attention-deficit/hyperactivity disorder (ADHD) medication misuse, abuse, dependence, diversion, and malingering. The review covers nonmedicalExpand
  • 83
  • 3
  • PDF
Long-term weight gain in patients treated with open-label olanzapine in combination with fluoxetine for major depressive disorder.
OBJECTIVE Patients with major depressive disorder (MDD) treated with olanzapine in combination with fluoxetine (OFC) demonstrate robust improvement in their depressive symptoms. Treatment withExpand
  • 42
  • 3
Atomoxetine Effects on Executive Function as Measured by the BRIEF-A in Young Adults with ADHD: A Randomized, Double-Blind, Placebo-Controlled Study
Objective To evaluate the effect of atomoxetine treatment on executive functions in young adults with attention-deficit/hyperactivity disorder (ADHD). Methods In this Phase 4, multi-center,Expand
  • 17
  • 3
  • PDF
Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder
Abstract Background: Attention-deficit/hyperactivity disorder (ADHD) is a CNS disorder that has its onset in childhood, but often persists into adulthood. There is growing recognition that adult ADHDExpand
  • 19
  • 2
Duloxetine Compared with Pregabalin for Diabetic Peripheral Neuropathic Pain Management in Patients with Suboptimal Pain Response to Gabapentin and Treated with or without Antidepressants: A Post Hoc
To examine the efficacy of duloxetine vs. pregabalin in the treatment for diabetic peripheral neuropathic pain (DPNP), comparing patient subgroups with and without concomitant antidepressant use.
  • 17
  • 2
Atomoxetine in patients with ADHD: A clinical and pharmacological review of the onset, trajectory, duration of response and implications for patients
This article reviews data providing new insight into the trajectory of response and maintenance of response of atomoxetine in the treatment of child and adult attention-deficit hyperactivity disorderExpand
  • 33
  • 1
A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities
Attention-deficit hyperactivity disorder (ADHD) is a common neuropsychiatric disorder that is often diagnosed during childhood, but has also increasingly been recognized to occur in adults.Expand
  • 16
  • 1
  • PDF
Atomoxetine-Related Change in Sluggish Cognitive Tempo Is Partially Independent of Change in Attention-Deficit/Hyperactivity Disorder Inattentive Symptoms.
OBJECTIVES To evaluate effects of atomoxetine versus placebo on sluggish cognitive tempo (SCT) and determine factors affecting improvement of SCT in children with attention-deficit/hyperactivityExpand
  • 4
  • 1
  • PDF
Atomoxetine monotherapy compared with combination therapy for the treatment of ADHD: a retrospective chart review study
Objective: To analyze Clinical Global Impression—Severity (CGI-S) in ADHD patients treated with atomoxetine (ATX) monotherapy versus ATX combination therapy with another ADHD-indicated medication.Expand
  • 3
  • 1
Misuse of Methylphenidate.
  • D. Clemow
  • Medicine
  • Current topics in behavioral neurosciences
  • 23 December 2015
This chapter reviews methylphenidate misuse, abuse, dependence, diversion, and malingering associated with its use as a prescription medication for attention-deficit/hyperactivity disorder and theExpand
  • 14
...
1
2
3
...